Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-053012
Filing Date
2008-09-22
Accepted
2008-09-22 19:26:55
Documents
2
Period of Report
2008-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4067
2 POA DOCUMENT poa.txt EX-24.4_257131 3502
  Complete submission text file 0001209191-08-053012.txt   9559
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGENERX BIOPHARMACEUTICALS, INC. 3 BETHESDA METRO CENTER - SUITE 630 BETHESDA MD 20814
Business Address (301) 961-1992
Bove Mauro (Reporting) CIK: 0001396271 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 081083369